Fall Epidemic Viral Pediatric Study
NCT01192178
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
339
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
FLOVENT™ DISKUS™ 100 mcg BID
DRUG:
ADVAIR™ DISKUS™ 100/50 mcg BID
Sponsor
GlaxoSmithKline